Down-Staging of EGFR Mutation-Positive Advanced Lung Carcinoma with Gefitinib Followed by Surgical Intervention: Follow-Up of Two Cases

Publisher： Karger

E-ISSN： 2296-5262|32|11|674-677

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.32, Iss.11, 2009-10, pp. : 674-677

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Afatinib, Erlotinib and Gefitinib in the First-Line Therapy of EGFR Mutation-Positive Lung Adenocarcinoma: A Review

By  

Oncology Research and Treatment, Vol. 36, Iss. 9, 2013-08 ,pp. : 510-518

Karger

Access to resources Recommend Favorite

Survival Outcomes in EGFR Mutation-Positive Lung Cancer Patients Treated with Gefitinib until or beyond Progression

By  

Oncology Research and Treatment, Vol. 39, Iss. 10, 2016-09 ,pp. : 605-614

Karger

Access to resources Recommend Favorite

Achievement of Cure with Gefitinib in Advanced Lung Adenocarcinoma Harboring an Activating EGFR Mutation: A Case Report

By  

Case Reports in Oncology, Vol. 9, Iss. 3, 2016-10 ,pp. : 565-567

Karger

Access to resources Recommend Favorite

PET/CT versus MRI for diagnosis, staging, and follow‐up of lung cancer

By  

JOURNAL OF MAGNETIC RESONANCE IMAGING, Vol. 42, Iss. 2, 2015-08 ,pp. : 247-260

John Wiley & Sons Inc

Access to resources Recommend Favorite

Currarino Triad: Surgical Management and Follow-Up Results of Three Cases

By  

Pediatric Neurosurgery, Vol. 46, Iss. 2, 2010-07 ,pp. : 110-119

Karger

Access to resources Recommend Favorite